A clinical study of mucocutaneous manifestation of HIV/AIDs and its correlation with CD4 count

Niya Khat, Chandramohan Kudligi, Ravi Munasingh Rathod, Vidya Kuntoji, Pradeep Vittal Bhagwat, Sanjay Thejaswi Ramachandra, Rashmi Laxman Chavan

Abstract


Background Acquired immune-deficiency syndrome (AIDS) is a fatal illness caused by a retrovirus known as Human Immunodeficiency Virus (HIV) which breaks down the immune system of the body, leaving the victim vulnerable to a host of life-threatening opportunistic infections, neurological disorders, or unusual malignancies. Dermatological disorders are health problems among HIV positive patients which present with a variety of manifestations. Skin diseases cause significant morbidity and may be initial signs of immunosuppression. They affect between 80 and 95% of HIV-infected patients, occurring at any time in the course of infection.

 

Objective 1- To study the pattern of mucocutaneous manifestation of HIV infected patients attending Dermatology Outpatient Department (OPD) of Karnataka Institute Of Medical Sciences (KIMS) Hubballi. 2- To assess the relation of mucocutaneous manifestations of HIV infected patients with CD4 count.

 

Methods All HIV positive patients with mucocutaneous manifestation attending Dermatology OPD, KIMS, Hubballi from December 2017 to May 2019 were enrolled.

 

Results  In this study, the most common dermatosis was pruritic papular eruption (21%) with a mean CD4 count of 499.81±319.31 cells/mm3. Among viral infections, the most common infection was herpes genitalis (32.4%) with a mean CD4 count of 291.25±194.22 cells/mm3. The most common fungal infection was dermatophytosis (59.1%) with a mean CD4 count of 489.69±260.13 cells/mm3. The most common bacterial infection was pyoderma (73.7%) and the mean CD4 count was 485.21±308.30 cells/mm3. The most common parasitic infestation was scabies with a mean CD4 count of 375.60±117.59 cells/mm3. Among malignancies, only two cases of basal cell carcinoma was seen in this study and the mean CD4 count was 89.50±57.28 cells/mm3.

 

Conclusion The skin manifestations in HIV can serve as an important marker for underlying immunodeficiency state. The CD4 count of a patient can be used to know the level of immunosuppression as different dermatosis are seen at various stages of HIV infection.

 


Keywords


AIDs; HIV; CD4 count; mucocutaneous

Full Text:

PDF

References


Christopher E.M. Griffith, Jonathan Barker, Tanya Blieker, Robert Chalmers, Daneil Creamer. Rook’s textbook of Dermatology. 9th edition. USA: John Wiley & Sons; 2016

WHO| HIV/AIDS; https://www.who.int/hiv/data/en/.

NACO| India HIV Estimations 2017; http://naco.gov.in/data-analysis-and-dissemination-unit-0.

Klaus Wolff, Lowell A.Goldsmith, Stephen I. Katz, Barbara A. Gilchrest, Ammy S. Paller, David J. Leffell. Fitzpatrick’s Dermatology in General medicine. 7th edition. USA: The McGraw-Hill Companies, Inc.2008.

Singh H, Singh P, Tiwari P, Dey V, Dulhani N, Singh A. Dermatological manifestations in HIV-infected patients at a tertiary care hospital in a tribal (Bastar) region of Chhattisgarh, India. Indian J Dermatol 2009; 54:338-41

DR Ampajwalam Kiran Raju. "Mucocutaneous Manifestations in HIV Patients in a tertiary care centre." IOSR Journal of Dental and Medical Sciences (IOSR-JDMS) 16.7 (2017): 58-64.

Kore SD, Kanwar AJ, Vinay K, Wanchu A. Pattern of mucocutaneous manifestations in human immunodeficiency virus-positive patients in North India. Indian J Sex Transm Dis AIDS. 2013;34(1):19.

Swamiappan M, Chandran V, Ramasamy S, et al. Pattern of mucocutaneous manifestations of HIV infected patients: a retrospective study. J. Evolution Med. Dent. Sci. 2016; 5(59): 4060-3.

DOI: 10.14260/jemds/2016/930.

Dash M, Meher SK, Padhi T. Profile of cutaneous diseases among HIV patients of Western Odisha. J. Evid. Based Med. Healthc. 2018; 5(24): 1852-7.

DOI: 10.18410/jebmh/2018/387.

Jindal N, Aggarwal A, Kaur S. HIV seroprevalence and HIV associated dermatoses among patients presenting with skin and mucocutaneous disorders. Indian J Dermatol Venereol Leprol 2009;75:283-6.

Shobhana A, Guha SK, Neogi DK. Mucocutaneous manifestations of HIV Infection. Indian J Dermatol Venereol Leprol 2004;70:82-6.

Chawhan SM, Bhat DM, Solanke SM. Dermatological manifestations in human immunodeficiency virus infected patients: Morphological spectrum with CD4 correlation. Indian J Sex Transm Dis 2013;34:89-94.

Davarpanah MA, Motazedian N, Jowkar F. Dermatological manifestations of HIV/AIDS individuals in Shiraz, South of Iran. J Global Infect Dis 2018;10:80-3.

Palω G, Benetti L, Calistri A. Molecular basis of the interactions between herpes simplex viruses and HIV-1. Herpes 2001:8:50-5.

Prerna Sharma, KrishnendraVarma, Meetesh Agarwal. “Pattern of Skin Disorders and their Relationship with CD4T Cell Count in HIV-Infected Children”. J Evol Med Dent Sci 2015; 4(40):6974-80. DOI:10.14260/jemds/2015/1013.

Crum-Cianflone N, Hullsiek KH, Satter E, et al. Cutaneous Malignancies Among HIV-Infected Persons. Arch Intern Med. 2009;169(12):1130–8.

Yunihastuti E, Widhani A, Karjadi TH; Drug hypersensitivity in human immunodeficiency virus-infected patient: challenging diagnosis and management. Asia Pac Allergy. 2014;4(1):54-67.

doi: 10.5415/apallergy.2014.4.1.54. Epub 2014 Jan 31.

Abhinandan HB, Jain SK, Nyati A, Kumar R, Jain M, Bhuria J, et al. Cutaneous manifestations of HIV-infection in relation with CD4 cell counts in Hadoti Region. J Evol Med Dent Sci 2013;2:7003-14.

Rao UK, Ranganathan K, Kumarasamy N. Gender differences in oral lesions among persons with HIV disease in Southern India. J Oral Maxillofac Pathol 2012;16:388-94.

Smith KJ, Skelton HG, DeRusso D, Sperling L, Yeager J, Wagner KF, et al. Clinical and histopathologic features of hair loss in patients with HIV-1 infection. J Am Acad Dermatol 1996;34:63-8.


Refbacks

  • There are currently no refbacks.


ISSN: 1560-9014